Latest news with #LUB
Time of India
23-05-2025
- Business
- Time of India
Waive risk-based inspections, urges MSME pharma body
Synopsis Laghu Udyog Bharati requests the government to waive risk-based inspections for companies upgrading their facilities. The association seeks an extension for Schedule M implementation for smaller firms. Concerns arise over inspections being conducted like raids. LUB highlights the role of MSMEs in supplying medicines during Covid. They request special attention for manufacturers with less than Rupees 50 crore turnover.
Economic Times
14-05-2025
- Health
- Economic Times
RSS-affiliated body urges Centre to scrap mandatory cough syrup export tests
Laghu Udyog Bharati (LUB) has appealed to the government to eliminate mandatory pre-export testing for cough syrups, citing delays and increased costs for small-scale manufacturers. This request follows the implementation of compulsory testing after reports linked India-made syrups to fatalities in Gambia. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads New Delhi: RSS affiliate Laghu Udyog Bharati (LUB), which supports the small-scale industry, has urged the government to drop the requirement of compulsory testing of cough syrups at a government-approved laboratory before exports, stating that it leads to delays and increased made the testing compulsory following reports that linked the death of several children in Gambia to "made in India" cough syrups."For the manufacturers and exporters, these are areas of concern as it results in potential delays and increased costs, particularly for export shipments," LUB all India general secretary Om Prakash Gupta wrote in a letter dated May 10 to union health minister JP Nadda He requested the minister to "provide a viable solution" addressing the concerns of the pharma to the LUB, the testing procedure often takes 45 days and the testing fee of '25,000 per batch is "quite hefty".It also sought exemption from testing for exporters of other syrups, suspensions, dry syrups, tablets, injections and infusions as there had been no critical complaints in the past two May 2023, the Directorate General of Foreign Trade notified that for exports, cough syrup manufacturers must produce a certificate of analysis from a government-approved followed incidents where India-made cough syrups imported into Gambia were allegedly found to be contaminated with diethylene glycol and ethylene glycol, resulting in an acute kidney injury cluster among children.
Time of India
14-05-2025
- Health
- Time of India
RSS-affiliated body urges Centre to scrap mandatory cough syrup export tests
New Delhi: RSS affiliate Laghu Udyog Bharati (LUB), which supports the small-scale industry, has urged the government to drop the requirement of compulsory testing of cough syrups at a government-approved laboratory before exports, stating that it leads to delays and increased cost. India made the testing compulsory following reports that linked the death of several children in Gambia to "made in India" cough syrups. "For the manufacturers and exporters, these are areas of concern as it results in potential delays and increased costs, particularly for export shipments," LUB all India general secretary Om Prakash Gupta wrote in a letter dated May 10 to union health minister JP Nadda . He requested the minister to "provide a viable solution" addressing the concerns of the pharma industry. According to the LUB, the testing procedure often takes 45 days and the testing fee of '25,000 per batch is "quite hefty". Live Events It also sought exemption from testing for exporters of other syrups, suspensions, dry syrups, tablets, injections and infusions as there had been no critical complaints in the past two years. In May 2023, the Directorate General of Foreign Trade notified that for exports, cough syrup manufacturers must produce a certificate of analysis from a government-approved laboratory. This followed incidents where India-made cough syrups imported into Gambia were allegedly found to be contaminated with diethylene glycol and ethylene glycol, resulting in an acute kidney injury cluster among children.
